Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+1.91M
-
Total reported value, excl. options
-
$229M
-
Value change
-
+$13.1M
-
Put/Call ratio
-
2.25
-
Number of buys
-
40
-
Number of sells
-
-16
-
Price
-
$6.87
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2019
80 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q1 2019.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 170M outstanding shares and own 19.59% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (5.82M shares), ARK Investment Management LLC (5.29M shares), BlackRock Inc. (2.2M shares), RENAISSANCE TECHNOLOGIES LLC (902K shares), VANGUARD GROUP INC (901K shares), Nikko Asset Management Americas, Inc. (818K shares), Sumitomo Mitsui Trust Holdings, Inc. (801K shares), JPMORGAN CHASE & CO (606K shares), and STATE STREET CORP (401K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.